Clinical Trial Update: First In Human Study of CX-801 in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This update announces the first-in-human Phase 1 study of CX-801 for adults with advanced solid tumors, currently recruiting to assess safety and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• CX-801

Snippet

Sponsor: CytomX Therapeutics | Conditions: Solid Tumor, Adult | Phase 1 | Status: RECRUITING